ExcepGen
PrivateLast Round
Seed
Aug 24, 2023
Est. Valuation
$2.14M
Total Funding Raised
$4.15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ExcepGen operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in August 2023.
ExcepGen is a biotechnology company that is developing a platform for nucleic acid therapeutics designed to improve the efficacy and tolerability of DNA and RNA-based medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExcepGen Comparables
Compare ExcepGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Replicate Bioscience | 78% | |
| Kernalbio | 77% | |
| eTheRNA | 76% |
For institutional investors. Book with your work email.
ExcepGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 24, 2023 | ||||
| Accelerator | Mar 15, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ExcepGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed |
| ZAKA VC | Seed |
| VitaDAO | Accelerator |
| Gravity Fund | Seed |
| Y Combinator | Accelerator |
| Gravity Fund | Seed |
| Apollo Projects | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 286% MoM, from 329 to 1.3K.
- Aug 24, 2023
$4M round led by RA Capital Management
For institutional investors. Book with your work email.
ExcepGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ExcepGen's valuation, stock price, and market status.
Is ExcepGen a public or private company?
ExcepGen is a private company.
What is the current stock price of ExcepGen?
ExcepGen is a private company, so its shares have no public market price. Caplight tracks ExcepGen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ExcepGen worth (valuation)?
ExcepGen's valuation is estimated at $2.1M based on funding round data.
Can I buy ExcepGen stock?
ExcepGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ExcepGen's last funding round?
ExcepGen's most recent funding round was Seed on August 24, 2023.
Who are the main investors in ExcepGen?
Key investors in ExcepGen include RA Capital Management.
Will ExcepGen IPO soon?
No public IPO plans have been announced for ExcepGen.
How can I track ExcepGen secondary market activity?
Caplight tracks bids, offers, and trades in ExcepGen's shares on secondary markets.